Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium
Sumanth C. Suresh, Vaithinathan Selvaraju, Mahesh Thirunavukkarasu, Joshua W. Goldman, Aaftab Husain, J. Alexander Palesty, Juan A. Sanchez, David W. McFadden, Nilanjana Maulik
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium'. Together they form a unique fingerprint.